0001645113-23-000007.txt : 20230109
0001645113-23-000007.hdr.sgml : 20230109
20230109181844
ACCESSION NUMBER: 0001645113-23-000007
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230105
FILED AS OF DATE: 20230109
DATE AS OF CHANGE: 20230109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Danziger Asaf
CENTRAL INDEX KEY: 0001654435
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 23519227
MAIL ADDRESS:
STREET 1: 5 NACHUM CHAT ST.
CITY: TIRAT HACARMEL
STATE: L3
ZIP: 5112302
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovoCure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
FORMER COMPANY:
FORMER CONFORMED NAME: Novocure Ltd
DATE OF NAME CHANGE: 20150615
4
1
wf-form4_167330630889022.xml
FORM 4
X0306
4
2023-01-05
0
0001645113
NovoCure Ltd
NVCR
0001654435
Danziger Asaf
C/O NOVOCURE INC.
1550 LIBERTY RIDGE DRIVE, SUITE 115
WAYNE
PA
19087
1
1
0
0
Chief Executive Officer
Ordinary Shares
2023-01-05
4
M
0
25000
11.46
A
38583
D
Ordinary Shares
2023-01-05
4
S
0
8369
111.2338
D
30214
D
Ordinary Shares
2023-01-05
4
S
0
2000
112.8632
D
28214
D
Ordinary Shares
2023-01-05
4
S
0
4568
114.3524
D
23646
D
Ordinary Shares
2023-01-05
4
S
0
3702
115.2113
D
19944
D
Ordinary Shares
2023-01-05
4
S
0
1395
116.0618
D
18549
D
Ordinary Shares
2023-01-05
4
S
0
999
117.0111
D
17550
D
Ordinary Shares
2023-01-05
4
S
0
2123
118.4714
D
15427
D
Ordinary Shares
2023-01-05
4
S
0
1344
119.3493
D
14083
D
Ordinary Shares
2023-01-05
4
S
0
500
119.987
D
13583
D
Ordinary Shares
2023-01-05
4
M
0
187500
7.15
A
201083
D
Ordinary Shares
2023-01-05
4
S
0
187500
108
D
13583
D
Ordinary Shares
2023-01-06
5
A
0
E
39
62.305
A
13622
D
Options to Buy Ordinary Shares
11.46
2023-01-05
4
M
0
25000
0
D
2026-02-24
Ordinary Shares
25000.0
0
D
Options to Buy Ordinary Shares
7.15
2023-01-05
4
M
0
187500
0
D
2027-02-22
Ordinary Shares
187500.0
0
D
Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Danziger.
On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 8,369 shares in multiple trades at prices ranging from $111.00 to $111.97. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 2,000 shares in multiple trades at prices ranging from $112.29 to $113.26. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 4,568 shares in multiple trades at prices ranging from $113.76 to $114.75. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 3,702 shares in multiple trades at prices ranging from $114.79 to $115.78. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 1,395 shares in multiple trades at prices ranging from $115.79 to $116.45. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 999 shares in multiple trades at prices ranging from $116.85 to $117.82. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 2,123 shares in multiple trades at prices ranging from $117.91 to $118.90. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 1,344 shares in multiple trades at prices ranging from $118.95 to $119.84. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 500 shares in multiple trades at prices ranging from $119.98 to $120.00. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
In accordance with the issuer's Employee Share Purchase Plan, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on July 1, 2022.
Fully vested as of the date hereof.
By: /s/ Steven Robbins, Attorney in Fact for Asaf Danziger
2023-01-09